PROS AND CONS OF AMINOGLUTETHIMIDE FOR ADVANCED POSTMENOPAUSAL BREAST-CANCER

被引：15
作者：
BRUNING, PF
BONFRER, JGM
ENGELSMAN, E
HAMERSMAVANDERLINDEN, E
DEJONGBAKKER, M
NOOYEN, W
机构：
来源：
BREAST CANCER RESEARCH AND TREATMENT | 1984年 / 4卷 / 04期
关键词：
D O I：
10.1007/BF01806041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：289 / 295
页数：7
相关论文
共 32 条
[1]  
BONFRER JMG, 1983, 3RD P EORTC BREAST C
[2]  
BRUNING PF, J STEROID BIOCH
[3]   AMINOGLUTETHIMIDE (ELIPTEN-CIBA) AS AN INHIBITOR OF ADRENAL STEROIDOGENESIS - MECHANISM OF ACTION AND THERAPEUTIC TRIAL [J].
CASH, R ;
BROUGH, AJ ;
COHEN, MNP ;
SATOH, PS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1967, 27 (09) :1239-+
[4]  
GOODMAN L, PHARM BASIS THERAPEU, P133
[5]  
GRIFFITHS CT, 1973, CANCER-AM CANCER SOC, V32, P31, DOI 10.1002/1097-0142(197307)32:1<31::AID-CNCR2820320104>3.0.CO
[6]  
2-5
[7]  
HALL T, 1969, CLIN RES, V12, P402
[8]  
HARVEY HA, 1979, CANCER, V43, P2207, DOI 10.1002/1097-0142(197906)43:6<2207::AID-CNCR2820430608>3.0.CO
[9]  
2-1
[10]  
HARVEY HA, 1982, CANCER RES, V42, P3451
1234